What is Stereotaxis's R&D?

Stereotaxis (STXS) reported R&D of $2.4M in Q1 2026.

How has Stereotaxis's R&D changed year-over-year?

Stereotaxis's R&D increased by 2.0% year-over-year, from $2.35M to $2.4M.

What is the long-term trend for Stereotaxis's R&D?

Over 4 years (2021 to 2025), Stereotaxis's R&D has grown at a -2.1% compound annual growth rate (CAGR), from $10.2M to $9.38M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Stereotaxis STXS R&D

R&D at other companies

AbbottABT

$767M+7.1%

MedtronicMDT

$671M-1.9%

StrykerSYK

$413M+2.0%

ITG

Integer HoldingsITGR

$16.24M+14.4%

Merit Medical SystemsMMSI

$22.61M+0.6%

iRadimedIRMD

$956K+53.2%

Other financials

Income statement

See full

Revenue$6.3M-15.8%

Gross profit$3.8M-6.6%

Operating income-$6.0M-0.9%

Net income-$5.9M-0.7%

EPS (diluted)-$0.06+14.3%

Balance sheet

See full

Cash & equivalents$14.6M+36.7%

Total debt$5.3M-10.0%

Total equity$14.4M+399%

Total assets$54.0M+18.2%

Cash flow

See full

Operating cash flow-$3.4M-93.5%

CapEx$79.0K—

Free cash flow-$3.5M—

Valuation

See full

Market cap$168.11M-11.6%

Enterprise value$158.77M-15.9%

P/S5.4×-0.6×

Profitability

See full

Gross margin53.9%+0.5pp

Operating margin-71%-14.0pp

Net margin-69.5%-13.7pp

FCF margin-35.5%-2.4pp

Returns & leverage

See full

Return on equity-251.5%-29.9pp

Debt / equity0.4×-1.7×

Current ratio1.6×+0.5×

Where this comes from

Reported directly by Stereotaxis in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Stereotaxis's R&D?: Stereotaxis (STXS) reported R&D of $2.4M in Q1 2026.
How has Stereotaxis's R&D changed year-over-year?: Stereotaxis's R&D increased by 2.0% year-over-year, from $2.35M to $2.4M.
What is the long-term trend for Stereotaxis's R&D?: Over 4 years (2021 to 2025), Stereotaxis's R&D has grown at a -2.1% compound annual growth rate (CAGR), from $10.2M to $9.38M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.